Angiotensin II generation by mast cell α- and β-chymases

被引:167
作者
Caughey, GH
Raymond, WW
Wolters, PJ
机构
[1] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY | 2000年 / 1480卷 / 1-2期
关键词
chymase; angiotensin; mast cell; dipeptidylpeptidase I;
D O I
10.1016/S0167-4838(00)00076-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mast cells secrete alpha- and beta-chymases. Primate alpha-chymases generate angiotensin (AT) II by selectively hydrolyzing AT I's Phe(8)-His(9) bond. This is distinct from the AT converting enzyme (ACE) pathway. In humans, alpha-chymase is the major non-ACE AT II-generator. In rats, beta-chymases destroy AT II by cleaving at Tyr(4)-Ile(5). Past studies predicted that AT II production versus destruction discriminates alpha- from beta-chymases and that Lys(40) in the substrate-binding pocket determines alpha-chymase Phe(8) specificity. This study examines these hypotheses by comparing AT II generation by human or-chymase (containing Lys(40)), dog alpha-chymase (lacking Lys(40)), and mouse mMCP-4 (a beta-chymase lacking Lys(40); orthologous to AT II-destroying rat chymase rMCP-1). The results suggest that human and dog alpha-chymase generate AT II exclusively and with comparable efficiency, although dog chymase contains Ala(40) rather than Lys(40). Furthermore, AT II is the major product generated by degranulation supernatants from cultured dog mast cells, which release tryptases and dipeptidylpeptidase as well as alpha-chymase. In contrast to rMCP-1, mMCP-4 beta-chymase readily generates AT II. Although there is competing AT I hydrolysis at Tyr(4) mMCP-4 does not destroy AT II quickly once it is formed. We conclude (1) that chymases are the dominant AT I-hydrolyzing mast cell peptidases, (2) that residues other than Lys(40) are key determinants of alpha-chymase AT I Phe(8) specificity, (3) that beta-chymases can generate AT II, and (4) that alpha- and beta-chymases are not strictly dichotomous regarding AT I cleavage specificity. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:245 / 257
页数:13
相关论文
共 54 条
  • [1] Differences in tissue angiotensin II-forming pathways by species and organs in vitro
    Akasu, M
    Urata, H
    Kinoshita, A
    Sasaguri, M
    Ideishi, M
    Arakawa, K
    [J]. HYPERTENSION, 1998, 32 (03) : 514 - 520
  • [2] Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species considerations
    Balcells, E
    Meng, QC
    Johnson, WH
    Oparil, S
    DellItalia, LJ
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 273 (04): : H1769 - H1774
  • [3] INHIBITORS OF HUMAN HEART CHYMASE BASED ON A PEPTIDE LIBRARY
    BASTOS, M
    MAEJI, NJ
    ABELES, RH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (15) : 6738 - 6742
  • [4] DOG MAST-CELL CHYMASE - MOLECULAR-CLONING AND CHARACTERIZATION
    CAUGHEY, GH
    RAYMOND, WW
    VANDERSLICE, P
    [J]. BIOCHEMISTRY, 1990, 29 (21) : 5166 - 5171
  • [5] CAUGHEY GH, 1988, IMMUNOLOGY, V63, P339
  • [6] THE HUMAN MAST-CELL CHYMASE GENE (CMA1) - MAPPING TO THE CATHEPSIN-G GRANZYME GENE-CLUSTER AND LINEAGE-RESTRICTED EXPRESSION
    CAUGHEY, GH
    SCHAUMBERG, TH
    ZERWECK, EH
    BUTTERFIELD, JH
    HANSON, RD
    SILVERMAN, GA
    LEY, TJ
    [J]. GENOMICS, 1993, 15 (03) : 614 - 620
  • [7] CAUGHEY GH, 1988, J PHARMACOL EXP THER, V244, P133
  • [8] Caughey GH, 1997, J IMMUNOL, V159, P4367
  • [9] CAUGHEY GH, 1991, J BIOL CHEM, V266, P12956
  • [10] PURIFICATION AND CHARACTERIZATION OF DOG MASTOCYTOMA CHYMASE - IDENTIFICATION OF AN OCTAPEPTIDE CONSERVED IN CHYMOTRYPTIC LEUKOCYTE PROTEINASES
    CAUGHEY, GH
    VIRO, NF
    LAZARUS, SC
    NADEL, JA
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 952 (02) : 142 - 149